Evercore ISI Group upgrades Clorox to In-Line from Underperform, keeps price target at $99

What happened

Evercore ISI Group upgraded Clorox from Underperform to In-Line, a more neutral rating, while keeping its price target at $99. The target implies 12.5% upside from Clorox’s October 30 closing price of $88. Other recent analyst targets listed in the article range from $80 to $90.

Confirmed

Global impact / market context

The upgrade signals that Evercore sees Clorox’s outlook as less negative than before, but it did not raise its $99 target. If investors respond by reassessing expected sales or costs, Clorox’s share price could move; the article gives no evidence of an actual market response.

Analyst inference

Evercore’s $99 target is above the $80–$90 range cited for five other recent analyst notes, while the article’s stated 12.5% upside uses an earlier closing price. That gap highlights differing analyst expectations, not a guaranteed return or consensus forecast.

Confirmed

What to watch

1. Check whether Clorox’s next reported sales and costs support a less negative outlook; the article provides no new company results or explanation for Evercore’s rating change. Analyst inference
2. Compare future analyst ratings and targets with Evercore’s $99 target and the cited $80–$90 range to see whether the gap narrows or persists. Analyst inference
3. Track Clorox’s share price against the October 30 close of $88; the stated 12.5% upside is based on that past price, not a promised gain. Confirmed

Evidence

• Original source link unavailable